You are here:News Home» Topic» Aurobindo Pharma»
submit to reddit

'Aurobindo Pharma' - 13 Video Result(s)

'Aurobindo Pharma' - 183 News Result(s)

  • Aurobindo Pharma Shares Fall as Q3 Net Dips

    Aurobindo Pharma Shares Fall as Q3 Net Dips

    Total expenses for the quarter ended December 2014 came in at Rs 7,298 crore compared to Rs 6,279.5 crore during the same period last financial year.

  • HDFC Bank, Tata Motors, Bharti Airtel in Focus Today

    HDFC Bank, Tata Motors, Bharti Airtel in Focus Today

    Indian stock markets have fallen for four straight days and Thursday's opening is unlikely to provide confidence to investors. Most global markets have been weighed down by concerns over Greek debt problems. Foreign investors sold stocks in cash mark...

  • Aurobindo Pharma Q3 Net Down 8% at Rs 384 Crore

    Aurobindo Pharma Q3 Net Down 8% at Rs 384 Crore

    Aurobindo Pharma on Wednesday reported a 7.93 per cent decline in consolidated net profit at Rs 384.35 crore for the third quarter that ended on December 31, 2014.

  • Nifty Set to Rebound, Bharti Airtel, Hero MotoCorp in Focus

    Nifty Set to Rebound, Bharti Airtel, Hero MotoCorp in Focus

    The Nifty is likely to reverse its three-day losing streak on Wednesday tracking positive global cues. Foreign investors, who bought cash shares worth Rs 17,700 crore in January, sold shares worth Rs 264 crore yesterday; domestic investors sold share...

  • Nifty Set for Strong Start on ECB Trigger; Cairn India in Focus

    Nifty Set for Strong Start on ECB Trigger; Cairn India in Focus

    The Nifty is set to join a global rally on Friday triggered by the European Central Bank's $1.15 trillion stimulus announcement. Indian stock markets have gained for six straight sessions, buoyed by strong buying by foreign investors. On Thursday, FI...

  • Aurobindo Pharma to Raise $350 Million Through QIP

    Aurobindo Pharma to Raise $350 Million Through QIP

    The board had earlier constituted a securities issue committee comprising of five board members, including two independent directors, for issue of securities.

  • Aurobindo, Actavis Recall Gabapentin Capsules

    Aurobindo, Actavis Recall Gabapentin Capsules

    According to notification by the US Food and Drug Administration (USFDA), the Indian firm's arm Aurobindo Pharma USA Inc has initiated a Class II nation wide recall. Each bottle contains 100 capsules of 300 mg.

  • 2014: Pharma Deals Worth Billions, Fines Worth Millions

    2014: Pharma Deals Worth Billions, Fines Worth Millions

    It has been a year of bitter medicine for Indian pharmaceutical companies with fines worth millions of dollars imposed by various foreign regulators, even as they stitched together deals worth billions of dollars, including a high profile merger betw...

  • Wipro, OnMobile Global, Auro Pharma in Focus Today

    Wipro, OnMobile Global, Auro Pharma in Focus Today

    The Nifty opened lower on Friday as indicated by futures trade on Singapore Stock Exchange. Foreign investors turned net sellers of Indian equities with increased intensity as they have sold stocks worth Rs 808 crore on Thursday. However domestic inv...

  • Infosys, SpiceJet, ICICI Bank in Focus Today

    Infosys, SpiceJet, ICICI Bank in Focus Today

    The Nifty opened flat on Monday as indicated by futures trade on Singapore Stock Exchange. Foreign investors remained net sellers of Indian equities on Friday as they had sold stocks worth Rs 109 crore in cash market. However domestic investors were ...

  • Aurobindo Pharma Completes $132.5 Million Natrol Acquisition

    Aurobindo Pharma Completes $132.5 Million Natrol Acquisition

    Aurobindo Pharma acquired "manufacturing assets, personnel, commercial infrastructure including the nutraceuticals brands in USA of Natrol along with an agreement to take on certain liabilities, with a bid of $132.5 million", the company said in a st...

  • Aurobindo Pharma Unit Recalls Anti-Epilepsy Drug in US

    Aurobindo Pharma Unit Recalls Anti-Epilepsy Drug in US

    Aurobindo Pharmas US-based unit is voluntarily recalling a lot of Gabapentin capsules, an anti-epilepsy drug, in the American market, as some empty capsules were found in certain batches.

  • Aurobindo Pharma to Raise $350 Million via Securities

    Aurobindo Pharma to Raise $350 Million via Securities

    Aurobindo Pharma has said it will raise $350 million (around Rs 2,166 crore) through issue of securities for funding its business expansion.

  • Constable Suspected in Attack on Top Executive in Hyderabad

    Constable Suspected in Attack on Top Executive in Hyderabad

    The man who tried to kidnap a top industrialist in Hyderabad on Wednesday, armed with an AK 47, is allegedly a policeman who was part of the "Greyhounds", an elite anti-Naxal commando force.

  • Aurobindo Pharma Promoter Nityananda Reddy Attacked, Shares Choppy

    Aurobindo Pharma Promoter Nityananda Reddy Attacked, Shares Choppy

    Aurobindo Pharma director and vice chairman K Nityananda Reddy was attacked by an unidentified man in the posh Banjara Hills area of Hyderabad today.

  • Aurobindo Pharma May Spend Rs 1,300 Crore Towards Capex in FY15-16

    Aurobindo Pharma May Spend Rs 1,300 Crore Towards Capex in FY15-16

    The capex will be spread out across APIs (active pharmaceutical ingredients) and formulations and the company's operations have resulted in substantial improvement to support the capex through internal cash generation, he said.

  • Aurobindo to Pharma Buy US Nutritional Supplements Maker for $133 Million

    Aurobindo to Pharma Buy US Nutritional Supplements Maker for $133 Million

    Aurobindo said the deal with Chatsworth, California-based Natrol, which sells vitamins and supplements as well as diet and weight management products, will help the company expand its over-the-counter products business in the United States.

  • Aurobindo Pharma July-September Quarter Net Rises 58% to Rs 372 Crore

    Aurobindo Pharma July-September Quarter Net Rises 58% to Rs 372 Crore

    The company had reported a net profit of Rs 235 crore in the year-ago period, it said in a statement.

  • Bullishness in Markets to Continue, Earnings, Key Data to Set Tone: Experts

    Bullishness in Markets to Continue, Earnings, Key Data to Set Tone: Experts

    The stock markets, which have hit back-to-back new highs, are expected to remain bullish in the holiday-shortened week, wherein earnings announcements and key macroeconomic data would dictate the trend, according to experts.

  • Nifty Climbs to 1-Month Closing High; Ranbaxy Up After Profit

    Nifty Climbs to 1-Month Closing High; Ranbaxy Up After Profit

    The Sensex rose 0.48 per cent, or 127.92 points, to end at 26,880.82. The broader Nifty gained 0.45 per cent, or 35.90 points, to end at 8,027.60, above the psychologically important 8,000 level.

  • Why Pharma Index Hit Record-High Today

    Why Pharma Index Hit Record-High Today

    Sun Pharma and Ranbaxy Lab rallied around 4 per cent to Rs 839.80 and Rs 627.40 respectively, whereas Glenmark Pharmaceuticals and Aurobindo Pharma were up between 4-6 per cent.

  • Vanguard Group Buys Aurobindo Pharma Shares Worth Rs 206 Crore

    Vanguard Group Buys Aurobindo Pharma Shares Worth Rs 206 Crore

    Investment management company Vanguard Group Inc on Friday picked up 23.60 lakh shares in Aurobindo Pharma for an estimated Rs 206.74 crore through the open market route.

  • Aurobindo Pharma Posts Net Profit of Rs 393.40 Crore in Q1

    Aurobindo Pharma Posts Net Profit of Rs 393.40 Crore in Q1

    Aurobindo Pharma on Thursday reported a consolidated net profit of Rs 393.40 crore in the first quarter that ended on June 30, 2014, on good performance of US generics, injectibles and anti-retro viral drugs.

  • Cadila Healthcare Recovers after Falling 10%

    Cadila Healthcare Recovers after Falling 10%

    The US Food and Drug Administration's observation letter could result in approval delays at a time when the Cadila's domestic revenues have been impacted by price controls.

Advertisement
Advertisement